Chad Cowan Century Therapeutics, Inc. (IPSC) insider trading activity

IPSC Quotes by TradingView

Chad Cowan is Chief Scientific Officer of Century Therapeutics, Inc.. Currently has a direct ownership of 1.04 Million shares of IPSC, which is worth approximately $490,433. The most recent transaction as insider was on Jan 02, 2026, when has been sold 1,611 shares (Common Stock) at a price of $1.0 per share, resulting in proceeds of $1,611. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.04M
5.14% 3M change
394.99% 12M change
Total Value Held $490,433

Chad Cowan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
SELL
Payment of exercise price or tax liability
$1,611 $1.0 p/Share
1,611 Reduced 0.15%
1,043,476 Common Stock
Dec 22 2025
BUY
Open market or private purchase
$49,351 $0.85 p/Share
58,060 Added 5.26%
1,045,087 Common Stock
Nov 20 2025
SELL
Open market or private sale
$2,731 $0.5 p/Share
5,462 Reduced 0.55%
987,027 Common Stock
Sep 18 2025
BUY
Grant, award, or other acquisition
-
762,543 Added 43.45%
992,489 Common Stock
Mar 11 2025
BUY
Grant, award, or other acquisition
-
19,500 Added 7.81%
230,306 Common Stock
Oct 01 2024
BUY
Grant, award, or other acquisition
-
74,376 Added 26.08%
210,806 Common Stock
CC

Chad Cowan

Chief Scientific Officer
Philadelphia, PA

Track Institutional and Insider Activities on IPSC

Follow Century Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

News

Receive news related to Century Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IPSC